BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38057668)

  • 21. Dendritic cell-NK cell cross-talk: regulation and physiopathology.
    Zitvogel L; Terme M; Borg C; Trinchieri G
    Curr Top Microbiol Immunol; 2006; 298():157-74. PubMed ID: 16323415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatment.
    Rahimi Kalateh Shah Mohammad G; Ghahremanloo A; Soltani A; Fathi E; Hashemy SI
    J Cell Physiol; 2020 Jul; 235(7-8):5449-5460. PubMed ID: 31970790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation.
    Krummel MF; Mahale JN; Uhl LFK; Hardison EA; Mujal AM; Mazet JM; Weber RJ; Gartner ZJ; Gérard A
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11585-11590. PubMed ID: 30348790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.
    Abel AM; Tiwari AA; Gerbec ZJ; Siebert JR; Yang C; Schloemer NJ; Dixon KJ; Thakar MS; Malarkannan S
    Front Immunol; 2018; 9():1168. PubMed ID: 29892299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling.
    Tam RC; Lim C; Bard J; Pai B
    J Immunol; 1999 Oct; 163(7):3709-17. PubMed ID: 10490966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine activation induces human memory-like NK cells.
    Romee R; Schneider SE; Leong JW; Chase JM; Keppel CR; Sullivan RP; Cooper MA; Fehniger TA
    Blood; 2012 Dec; 120(24):4751-60. PubMed ID: 22983442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses.
    van Deuren RC; Arts P; Cavalli G; Jaeger M; Steehouwer M; van de Vorst M; Gilissen C; Joosten LAB; Dinarello CA; Mhlanga MM; Kumar V; Netea MG; van de Veerdonk FL; Hoischen A
    Genome Med; 2021 May; 13(1):94. PubMed ID: 34034819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.
    Xia D; Li F; Xiang J
    Cancer Biother Radiopharm; 2004 Jun; 19(3):322-30. PubMed ID: 15285878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cancer-natural killer cell immunity cycle.
    Huntington ND; Cursons J; Rautela J
    Nat Rev Cancer; 2020 Aug; 20(8):437-454. PubMed ID: 32581320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions.
    Minami K; Yanagawa Y; Iwabuchi K; Shinohara N; Harabayashi T; Nonomura K; Onoé K
    Blood; 2005 Sep; 106(5):1685-93. PubMed ID: 15878981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
    Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
    Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dual effects of interleukin-18 in tumor progression.
    Park S; Cheon S; Cho D
    Cell Mol Immunol; 2007 Oct; 4(5):329-35. PubMed ID: 17976312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection.
    Dixon KJ; Siebert JR; Wang D; Abel AM; Johnson KE; Riese MJ; Terhune SS; Tarakanova VL; Thakar MS; Malarkannan S
    Mol Immunol; 2021 Sep; 137():94-104. PubMed ID: 34242922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional cytokine responses to pulmonary aspergillosis in immunocompetent rats.
    El-Muzghi AA; Mirkov I; Djokic J; Popov Aleksandrov A; Miljkovic D; Glamoclija J; Kataranovski D; Kataranovski M
    Immunobiology; 2013 Dec; 218(12):1514-23. PubMed ID: 23810257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.
    Li Y; Zhang Y; Cao G; Zheng X; Sun C; Wei H; Tian Z; Xiao W; Sun R; Sun H
    J Hematol Oncol; 2021 Jun; 14(1):100. PubMed ID: 34174928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System.
    Oyler-Yaniv A; Oyler-Yaniv J; Whitlock BM; Liu Z; Germain RN; Huse M; Altan-Bonnet G; Krichevsky O
    Immunity; 2017 Apr; 46(4):609-620. PubMed ID: 28389069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.